Financial Year |
March 31 2023 |
Monetary Funds |
3,972,127,744.57 |
Held-for-trading Financial Assets |
386,536,806.18 |
Notes Receivable |
301,448,416.00 |
Accounts Receivable |
1,517,409,522.04 |
Advances to Suppliers |
66,611,279.48 |
Other Receivables |
27,020,213.98 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
800,382,607.05 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
124,985,512.78 |
Total Current Assets |
9,234,185,709.37 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
302,774,508.66 |
Investment Properties |
86,005,130.41 |
Fixed Assetes |
1,711,448,228.51 |
Under-construction Projects |
1,776,355,878.21 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
684,089,722.08 |
R&D expenses |
4,180,794.61 |
Goodwill |
419,379,155.43 |
Long-Term Deferred and Prepaid Expenses |
92,149,290.20 |
Deferred Income Tax Assets |
96,068,603.00 |
Other Non-Current Assets |
496,864,250.40 |
Sub-Total of Non-Current Assets |
6,080,855,479.25 |
Total Assets |
15,315,041,188.62 |
Short-Term Loans |
110,552,685.06 |
Trading Financial liabilities |
166,666.68 |
Notes Payable |
1,918,051,287.06 |
Accounts Payable |
594,049,316.46 |
Accounts Received In Advance |
53,684.87 |
Employee Compensation Payable |
143,015,518.61 |
Taxes Payable |
51,161,997.29 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
314,574,477.23 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
310,268,238.23 |
Other Current Liabilities |
120,244,102.11 |
Sub-Total of Current Liabilities |
3,598,260,354.20 |
Long-term Loans |
444,800,000.00 |
Bonds Payable |
1,711,062,280.69 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
83,488,528.55 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,477,104,828.13 |
Total Liabilities |
6,075,365,182.33 |
Paid-In Capital(Or Share Stock) |
745,698,703.00 |
Capital Surplus |
2,544,655,149.87 |
Surplus Reserve |
337,452,028.92 |
LESS:Treasury Stock |
85,804,021.60 |
Undistributed Profits |
4,627,248,185.36 |
Minority Stockholder's Interest |
564,333,213.44 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,675,342,792.85 |
Owner's Equity(Stockholder's Equity) |
9,239,676,006.29 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
15,315,041,188.62 |